Protein N-homocysteinylation induces the formation of toxic amyloid-like protofibrils

Journal of Molecular Biology

Volumn 400, Issue 4, 2010, Pages 889-907

  Paoli, Paolo ^a   Sbrana, Francesca ^a   Tiribilli, Bruno ^b   Caselli, Anna ^a   Pantera, Barbara ^a   Cirri, Paolo ^a   De Donatis, Alina ^a   Formigli, Lucia ^a   Nosi, Daniele ^a   Manao, Giampaolo ^a   Camici, Guido ^a   Ramponi, Giampietro ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b ISTITUTO DEI SISTEMI COMPLESSI   (Italy)

Author keywords

Homocysteine; Homocysteine thiolactone; Protein aggregation; Protein homocysteinylation

Indexed keywords

AMYLOID; BOVINE SERUM ALBUMIN; CONGO RED; HOMOCYSTEINE THIOLACTONE; THIOFLAVINE;

ARTICLE; ATOMIC FORCE MICROSCOPY; CELL CULTURE; CELL FUNCTION; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; FLUORESCENCE; HEATING; LIGHT SCATTERING; N HOMOCYSTEINYLATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; SPECTROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; TURBIDITY;

BOVINAE;

EID: 77954357800     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2010.05.039     Document Type: Article

References (49)

1. Ramponi G., Grisolia S. Acylation of lysine and of arginine-rich histones with carbamyl phosphate and 1,3 diphosphoglycerate. Biochem. Biophys. Res. Commun. 1970, 38:1056-1063.
2. Ramponi G., Leaver J.L., Grisolia S. Homocitrulline formation following carbamylation of histones with carbamyl phosphate. FEBS Lett. 1971, 16:311-314.
3. Ramponi G., Manao G., Camici G. Nonenzymatic acetylation of histones with acetyl phosphate and acetyl adenylate. Biochemistry 1975, 14:2681-2685.
4. Kraus L.M., Gaber L., Handorf C.R., Marti H.P., Kraus A.P. Carbamoylation of glomerular and tubular proteins in patients with kidney failure: a potential mechanism of ongoing renal damage. Swiss Med. Wkly. 2001, 131:139-145.
5. Ganea E., Harding J.J. Inhibition of 6-phosphogluconate dehydrogenase by carbamylation and protection by alpha-crystallin, a chaperone-like protein. Biochem. Biophys. Res. Commun. 1996, 222:626-631.
6. Hawkins D., Pinckard R.N., Crawford I.P., Farr R.S. Structural changes in human serum albumin induced by ingestion of acetylsalicylic acid. J. Clin. Invest. 1969, 48:536-542.
7. Yvon M., Wal J.M. Identification of lysine residue 199 of human serum albumin as a binding site for benzylpenicilloyl groups. FEBS Lett. 1988, 239:237-240.
8. Nie C.L., Wang X.S., Liu Y., Perrett S., He R.Q. Amyloid-like aggregates of neuronal tau induced by formaldehyde promote apoptosis of neuronal cells. BMC Neurosci. 2007, 8:9.
9. Derham B.K., Harding J.J. Effects of modifications of alpha-crystallin on its chaperone and other properties. Biochem. J. 2002, 364:711-717.
10. Harrington C.R., Colaco C.A. Alzheimer's disease. A glycation connection. Nature 1994, 370:247-248.
11. Chang H., Ewert S.M., Bookchin R.M., Nagel R.L. Comparative evaluation of fifteen anti-sickling agents. Blood 1983, 61:693-704.
12. Jakubowski H., Goldman E. Synthesis of homocysteine thiolactone by methionyl-tRNA synthetase in cultured mammalian cells. FEBS Lett. 1993, 317:237-240.
13. Jakubowski H. Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels. FASEB J. 1999, 13:2277-2283.
14. Jakubowski H. Homocysteine thiolactone: metabolic origin and protein homocysteinylation in humans. J. Nutr. 2000, 130:377S-381S.
15. Jakubowski H. Metabolism of homocysteine thiolactone in human cell cultures. Possible mechanism for pathological consequences of elevated homocysteine levels. J. Biol. Chem. 1997, 272:1935-1942.
16. Jakubowski H., Zhang L., Bardeguez A., Aviv A. Homocysteine thiolactone and protein homocysteinylation in human endothelial cells: implications for atherosclerosis. Circ. Res. 2000, 87:45-51.
17. Chwatko G., Boers G.H., Strauss K.A., Shih D.M., Jakubowski H. Mutations in methylenetetrahydrofolate reductase or cystathionine beta-synthase gene, or a high-methionine diet, increase homocysteine thiolactone levels in humans and mice. FASEB J. 2007, 21:1707-1713.
18. Jakubowski H., Boers G.H., Strauss K.A. Mutations in cystathionine beta-synthase or methylenetetrahydrofolate reductase gene increase N-homocysteinylated protein levels in humans. FASEB J. 2008, 22:4071-4076.
19. Jakubowski H., Perla-Kajan J., Finnell R.H., Cabrera R.M., Wang H., Gupta S., et al. Genetic or nutritional disorders in homocysteine or folate metabolism increase protein N-homocysteinylation in mice. FASEB J. 2009, 23:1721-1727.
20. Jakubowski H. Protein N-homocysteinylation: implications for atherosclerosis. Biomed. Pharmacother. 2001, 55:443-447.
21. Jakubowski H. Molecular basis of homocysteine toxicity in humans. Cell. Mol. Life Sci. 2004, 61:470-487.
22. Jakubowski H. Pathophysiological consequences of homocysteine excess. J. Nutr. 2006, 136:1741S-1749S.
23. Jakubowski H. The molecular basis of homocysteine thiolactone-mediated vascular disease. Clin. Chem. Lab. Med. 2007, 45:1704-1716.
24. Jakubowski H. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease. J. Physiol. Pharmacol. 2008, 59:155-167.
25. Perła-Kajan J., Marczak ł., Kajan L., Skowronek P., Twardowski T., Jakubowski H. Modification by homocysteine thiolactone affects redox status of cytochrome C. Biochemistry 2007, 46:6225-6231.
26. Perła-Kajan J., Twardowski T., Jakubowski H. Mechanisms of homocysteine toxicity in humans. Amino Acids 2007, 32:561-572.
27. Glowacki R., Jakubowski H. Cross-talk between Cys34 and lysine residues in human serum albumin revealed by N-homocysteinylation. J. Biol. Chem. 2004, 279:10864-10871.
28. Lashuel H.A., Hartley D., Petre B.M., Walz T., Lansbury P.T. Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 2002, 418:291.
29. Rongxin S., Wei Q., Zhimin H., Yubin Z., Fengmin J. Multilevel structural nature and interactions of bovine serum albumin during heat-induced aggregation process. Food Hydrocolloids 2008, 22:995-1005.
30. Sreerema N., Venyaminov S.Y., Woody R.W. Estimation of the number of helical and strand segment in proteins using CD spectroscopy. Protein Sci. 1999, 8:370-380.
31. Klunk W.E., Jacob R.F., Mason R.P. Quantifying amyloid by congo red spectral shift assay. Methods Enzymol. 1999, 309:285-305.
32. Stathopulos P.B., Scholz G.A., Hwang Y.-M., Rumfeldt J.A.O., Lepock J.R., Meiering E.M. Sonication of proteins causes formation of aggregates that resemble amyloid. Protein Sci. 2004, 13:3017-3027.
33. Aoneng C., Daoying H., Luhua L. Formation of amyloid fibrils from fully reduced hen egg white lysozyme. Protein Sci. 2004, 13:319-324.
34. Holm N.K., Jespersen S.K., Thomassen L., Wolff T.Y., Sehgal P., Thomsen L.A., et al. Aggregation and fibrillation of bovine serum albumin. Biochim. Biophys. Acta 2007, 1774:1128-1138.
35. Undas A., Perla J., Lacinski M., Trzeciak W., Kazmierski R., Jakubowski H. Autoantibodies against N-homocysteinylated proteins in humans: implications for atherosclerosis. Stroke 2004, 35:1299-1304.
36. Jakubowski H. Homocysteine is a protein amino acid in humans. Implications for homocysteine-linked disease. J. Biol. Chem. 2002, 277:30425-30428.
37. Ferretti G., Bacchetti T., Rabini R.A., Vignini A., Nanetti L., Moroni C., Mazzanti L. Homocysteinylation of low-density lipoproteins (LDL) from subjects with Type 1 diabetes: effect on oxidative damage of human endothelial cells. Diabet. Med. 2006, 23:808-813.
38. Conway K.A., Rochet J.C., Bieganski R.M., Lansbury P.T. Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 2001, 294:1346-1349.
39. Okochi M., Walter J., Koyama A., Nakajo S., Baba M., Iwatsubo T., et al. Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein. J. Biol. Chem. 2000, 275:390-397.
40. Emamian E., Kaytor M., Duvick L., Zu T., Tousey S., Zoghbi H., et al. Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice. Neuron 2003, 38:375-387.
41. Giasson B.I., Duda J.E., Murray I.V., Chen Q., Souza J.M., Hurtig H.I., et al. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 2000, 290:985-989.
42. Kuret J., Congdon E.E., Li G., Yin H., Yu X., Zhong Q. Evaluating triggers and enhancers of tau fibrillization. Microsc. Res. Tech. 2005, 67:141-155.
43. Nie C.L., Wei Y., Chen X., Liu Y.Y., Dui W., Liu Y., et al. Formaldehyde at low concentration induces protein tau into globular amyloid-like aggregates in vitro and in vivo. PLoS ONE 2007, 2:e629.
44. Wei Y., Chen L., Chen J., Ge L., He R.Q. Rapid glycation with d-ribose induces globular amyloid-like aggregations of BSA with high cytotoxicity to SH-SY5Y cells. BMC Cell Biol. 2009, 10:10.
45. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
46. Ellman G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959, 82:70-77.
47. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
48. Horcas I., Fernandez R., Gomez-Rodriguez J.M., Colchero J., Gomez-Herrero J., Baro A.M. WSXM: a software for scanning probe microscopy and a tool for nanotechnology. Rev. Sci. Instrum. 2007, 78:013705.
49. Abe K., Kimura H. Amyloid beta toxicity consists of a Ca(2+)-independent early phase and a Ca(2+)-dependent late phase. J. Neurochem. 1996, 67:2074-2078.